Drug for inducing bone marrow mesenchymal stem cell (MSC) differentiation to cardiomyocyte and detection method thereof
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- ZHEJIANG CANCER HOSPITAL
- Publication Date
- 2019-04-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a medicine for inducing bone marrow mesenchymal stem cells to differentiate cardiomyocytes and a detection method. Background technique
[0002] At present, the existing technologies commonly used in the industry are as follows:
[0003] Cardiovascular disease is one of the most important diseases that threaten human health in the world today, and its morbidity and mortality have surpassed tumor diseases and ranked first in the world. According to modern research, there are a variety of clinical cardiovascular diseases that pose a great threat to human life, such as coronary heart disease and heart failure, all caused by myocardial tissue damage and necrosis. This is due to the lack of regenerative ability of mature cardiomyocytes in myocardial tissue. After myocardial ischemia and infarction, cardiomyocytes (CM) will be damaged and die in a lar...